vs
GE医疗（CCRN）与南玻集团（CSGS）财务数据对比。点击上方公司名可切换其他公司
南玻集团的季度营收约是GE医疗的1.4倍（$323.1M vs $236.8M），南玻集团净利率更高（2.2% vs -35.0%，领先37.2%），南玻集团同比增速更快（2.0% vs -23.6%），南玻集团自由现金流更多（$55.8M vs $16.1M），过去两年南玻集团的营收复合增速更高（4.6% vs -21.0%）
GE医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业，品牌标识为GE HealthCare。公司主要业务分为四大板块：包含分子影像、CT、磁共振、妇科筛查及X光设备的医学影像业务、超声业务，以及聚焦远程患者监测、麻醉呼吸护理、心脏诊断、婴幼儿护理的患者护理解决方案业务，此外还开展医药相关业务。
中国南玻集团股份有限公司是中国规模最大的建筑玻璃生产商，业务涵盖浮法玻璃、建筑玻璃、显示玻璃、汽车玻璃、镀膜玻璃、镜子、彩滤玻璃、太阳能玻璃及节能玻璃等各类玻璃产品的研发、生产与销售，产品广泛应用于建筑、消费电子、新能源汽车、光伏等多个领域。
CCRN vs CSGS — 直观对比
营收规模更大
CSGS
是对方的1.4倍
$236.8M
营收增速更快
CSGS
高出25.6%
-23.6%
净利率更高
CSGS
高出37.2%
-35.0%
自由现金流更多
CSGS
多$39.7M
$16.1M
两年增速更快
CSGS
近两年复合增速
-21.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $236.8M | $323.1M |
| 净利润 | $-82.9M | $7.0M |
| 毛利率 | — | 50.0% |
| 营业利润率 | -30.2% | 9.0% |
| 净利率 | -35.0% | 2.2% |
| 营收同比 | -23.6% | 2.0% |
| 净利润同比 | -2109.7% | -79.7% |
| 每股收益（稀释后） | $-2.56 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CCRNCSGS
| Q4 25 | $236.8M | $323.1M | ||
| Q3 25 | $250.1M | $303.6M | ||
| Q2 25 | $274.1M | $297.1M | ||
| Q1 25 | $293.4M | $299.5M | ||
| Q4 24 | $309.9M | $316.7M | ||
| Q3 24 | $315.1M | $295.1M | ||
| Q2 24 | $339.8M | $290.3M | ||
| Q1 24 | $379.2M | $295.1M |
净利润CCRNCSGS
| Q4 25 | $-82.9M | $7.0M | ||
| Q3 25 | $-4.8M | $20.5M | ||
| Q2 25 | $-6.7M | $12.3M | ||
| Q1 25 | $-490.0K | $16.1M | ||
| Q4 24 | $-3.8M | $34.5M | ||
| Q3 24 | $2.6M | $19.1M | ||
| Q2 24 | $-16.1M | $13.8M | ||
| Q1 24 | $2.7M | $19.5M |
毛利率CCRNCSGS
| Q4 25 | — | 50.0% | ||
| Q3 25 | 20.4% | 48.1% | ||
| Q2 25 | 20.4% | 49.5% | ||
| Q1 25 | 20.0% | 48.4% | ||
| Q4 24 | — | 51.3% | ||
| Q3 24 | 20.4% | 49.4% | ||
| Q2 24 | 20.8% | 47.3% | ||
| Q1 24 | 20.4% | 46.5% |
营业利润率CCRNCSGS
| Q4 25 | -30.2% | 9.0% | ||
| Q3 25 | -2.4% | 10.0% | ||
| Q2 25 | -2.1% | 10.0% | ||
| Q1 25 | -0.3% | 9.8% | ||
| Q4 24 | -1.1% | 13.4% | ||
| Q3 24 | 0.9% | 10.8% | ||
| Q2 24 | -5.7% | 8.8% | ||
| Q1 24 | 0.8% | 10.8% |
净利率CCRNCSGS
| Q4 25 | -35.0% | 2.2% | ||
| Q3 25 | -1.9% | 6.7% | ||
| Q2 25 | -2.4% | 4.1% | ||
| Q1 25 | -0.2% | 5.4% | ||
| Q4 24 | -1.2% | 10.9% | ||
| Q3 24 | 0.8% | 6.5% | ||
| Q2 24 | -4.7% | 4.8% | ||
| Q1 24 | 0.7% | 6.6% |
每股收益（稀释后）CCRNCSGS
| Q4 25 | $-2.56 | $0.24 | ||
| Q3 25 | $-0.15 | $0.73 | ||
| Q2 25 | $-0.20 | $0.44 | ||
| Q1 25 | $-0.02 | $0.57 | ||
| Q4 24 | $-0.13 | $1.20 | ||
| Q3 24 | $0.08 | $0.67 | ||
| Q2 24 | $-0.47 | $0.48 | ||
| Q1 24 | $0.08 | $0.68 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $108.7M | $180.0M |
| 总债务越低越好 | — | $539.5M |
| 股东权益账面价值 | $322.8M | $283.7M |
| 总资产 | $449.0M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 1.90× |
8季度趋势，按日历期对齐
现金及短期投资CCRNCSGS
| Q4 25 | $108.7M | $180.0M | ||
| Q3 25 | $99.1M | $158.4M | ||
| Q2 25 | $81.2M | $145.9M | ||
| Q1 25 | $80.7M | $136.0M | ||
| Q4 24 | $81.6M | $161.8M | ||
| Q3 24 | $64.0M | $118.4M | ||
| Q2 24 | $69.6M | $110.4M | ||
| Q1 24 | $5.2M | $120.8M |
总债务CCRNCSGS
| Q4 25 | — | $539.5M | ||
| Q3 25 | — | $538.6M | ||
| Q2 25 | — | $537.8M | ||
| Q1 25 | — | $537.6M | ||
| Q4 24 | — | $538.5M | ||
| Q3 24 | — | $539.5M | ||
| Q2 24 | — | $540.5M | ||
| Q1 24 | — | $541.5M |
股东权益CCRNCSGS
| Q4 25 | $322.8M | $283.7M | ||
| Q3 25 | $408.1M | $289.5M | ||
| Q2 25 | $412.2M | $290.7M | ||
| Q1 25 | $418.2M | $283.1M | ||
| Q4 24 | $419.0M | $282.6M | ||
| Q3 24 | $424.7M | $288.4M | ||
| Q2 24 | $433.3M | $273.3M | ||
| Q1 24 | $462.4M | $269.3M |
总资产CCRNCSGS
| Q4 25 | $449.0M | $1.5B | ||
| Q3 25 | $538.2M | $1.5B | ||
| Q2 25 | $553.8M | $1.4B | ||
| Q1 25 | $576.2M | $1.4B | ||
| Q4 24 | $589.3M | $1.5B | ||
| Q3 24 | $597.4M | $1.4B | ||
| Q2 24 | $602.9M | $1.4B | ||
| Q1 24 | $648.4M | $1.3B |
负债/权益比CCRNCSGS
| Q4 25 | — | 1.90× | ||
| Q3 25 | — | 1.86× | ||
| Q2 25 | — | 1.85× | ||
| Q1 25 | — | 1.90× | ||
| Q4 24 | — | 1.91× | ||
| Q3 24 | — | 1.87× | ||
| Q2 24 | — | 1.98× | ||
| Q1 24 | — | 2.01× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $18.2M | $59.2M |
| 自由现金流经营现金流 - 资本支出 | $16.1M | $55.8M |
| 自由现金流率自由现金流/营收 | 6.8% | 17.3% |
| 资本支出强度资本支出/营收 | 0.9% | 1.1% |
| 现金转化率经营现金流/净利润 | — | 8.46× |
| 过去12个月自由现金流最近4个季度 | $40.1M | $141.4M |
8季度趋势，按日历期对齐
经营现金流CCRNCSGS
| Q4 25 | $18.2M | $59.2M | ||
| Q3 25 | $20.1M | $47.9M | ||
| Q2 25 | $4.2M | $37.3M | ||
| Q1 25 | $5.7M | $11.5M | ||
| Q4 24 | $24.2M | $82.5M | ||
| Q3 24 | $7.5M | $39.5M | ||
| Q2 24 | $82.4M | $43.1M | ||
| Q1 24 | $6.0M | $-29.4M |
自由现金流CCRNCSGS
| Q4 25 | $16.1M | $55.8M | ||
| Q3 25 | $17.9M | $43.9M | ||
| Q2 25 | $2.3M | $34.6M | ||
| Q1 25 | $3.8M | $7.1M | ||
| Q4 24 | $21.7M | $76.6M | ||
| Q3 24 | $6.3M | $32.0M | ||
| Q2 24 | $79.6M | $38.8M | ||
| Q1 24 | $3.8M | $-34.1M |
自由现金流率CCRNCSGS
| Q4 25 | 6.8% | 17.3% | ||
| Q3 25 | 7.2% | 14.5% | ||
| Q2 25 | 0.8% | 11.6% | ||
| Q1 25 | 1.3% | 2.4% | ||
| Q4 24 | 7.0% | 24.2% | ||
| Q3 24 | 2.0% | 10.8% | ||
| Q2 24 | 23.4% | 13.4% | ||
| Q1 24 | 1.0% | -11.6% |
资本支出强度CCRNCSGS
| Q4 25 | 0.9% | 1.1% | ||
| Q3 25 | 0.9% | 1.3% | ||
| Q2 25 | 0.7% | 0.9% | ||
| Q1 25 | 0.6% | 1.5% | ||
| Q4 24 | 0.8% | 1.9% | ||
| Q3 24 | 0.4% | 2.5% | ||
| Q2 24 | 0.8% | 1.5% | ||
| Q1 24 | 0.6% | 1.6% |
现金转化率CCRNCSGS
| Q4 25 | — | 8.46× | ||
| Q3 25 | — | 2.34× | ||
| Q2 25 | — | 3.04× | ||
| Q1 25 | — | 0.71× | ||
| Q4 24 | — | 2.39× | ||
| Q3 24 | 2.92× | 2.07× | ||
| Q2 24 | — | 3.12× | ||
| Q1 24 | 2.23× | -1.51× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
CSGS
| Software As A Service And Related Solutions | $287.2M | 89% |
| License And Service | $22.6M | 7% |
| Maintenance | $13.3M | 4% |
